enVVeno Medical
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
-6.5614.19
Price/Sales ratio
N/AN/A
Earnings per Share (EPS)
$-0.67$0.31

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-30.75-35.83-16.96-6.51-1.05-1.13-1.25-3.53-2.35-2.68-2.30-1.13
Price/Sales ratio
132.38N/A73.12120.3174.03277.44N/AN/AN/AN/AN/A277.44
Price/Book Value ratio
-15.56-16.06-13.62-4.566.788.751.571.051.471.361.478.75
Price/Cash Flow ratio
257.17K-28.45-18.63-12.08-2.17-1.47-1.45-4.82-3.66-3.35-3.64-1.47
Price/Free Cash Flow ratio
344.58K-28.42-16.61-12.05-2.16-1.38-1.42-4.68-3.64-3.34-3.61-1.38
Price/Earnings Growth ratio
N/A2.54-0.15-0.04-0.010.010.020.04-0.150.23-0.020.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
44.05%N/A-3.10%0.58%100%100%N/AN/AN/AN/AN/A100%
Operating Profit Margin
-402.81%N/A-592.83%-1445.88%-4210.50%-24566.50%N/AN/AN/AN/AN/A-4210.50%
Pretax Profit Margin
-430.50%N/A-711.05%-1845.83%-6991.46%-24406.73%N/AN/AN/AN/AN/A-6991.46%
Net Profit Margin
-430.50%N/A-431.02%-1845.83%-6991.46%-24406.73%N/AN/AN/AN/AN/A-6991.46%
Effective Tax Rate
N/A-22.80%38.34%-2.68%-12.82%-11.32%2.35%2.00%1.47%N/AN/A-12.82%
Return on Assets
-63.73%-55.79%-190.00%-351.77%-366.42%-222.04%-84.64%-28.07%-58.33%-48.35%-59.21%-366.42%
Return On Equity
50.61%44.84%80.28%70.00%-640.46%-770.28%-125.67%-29.77%-62.75%-50.90%-55.04%-640.46%
Return on Capital Employed
47.36%72.44%1642.17%102.40%-385.71%-492.67%-124.26%-30.10%-62.12%-53.39%-62.12%-385.71%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A25.77N/A
Quick Ratio
0.130.380.140.021.860.753.0034.8325.7734.2225.511.86
Cash ratio
0.010.340.020.001.790.692.9234.632.972.642.971.79
Days of Sales Outstanding
N/AN/A92.7630.4262.65N/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/A40.94N/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/A133.7130.42N/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
1.93K1.79K244.121.26KN/AN/A1.32K451.30450.51285.44N/AN/A
Cash Conversion Cycle
-1.93KN/A-110.40-1.23KN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.660.630.351.18N/A0.080.020.000.000.000.070.08
Debt Equity Ratio
-0.53-0.51-0.14-0.23N/A0.290.040.000.000.000.070.29
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.03N/A
Total Debt to Capitalization
-1.13-1.04-0.17-0.30N/A0.220.040.000.000.000.040.22
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-593.61N/A
Cash Flow to Debt Ratio
0.00-1.10-4.87-1.60N/A-20.42-24.55-40.69-49.74-55.79-9.10-9.10
Company Equity Multiplier
-0.79-0.80-0.42-0.191.743.461.481.061.071.051.073.46
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.00N/A-3.92-9.95-34.07-188.72N/AN/AN/AN/AN/A-34.07
Free Cash Flow / Operating Cash Flow Ratio
0.741.001.121.001.001.061.021.031.001.001.001.00
Cash Flow Coverage Ratio
0.00-1.10-4.87-1.60N/A-20.42-24.55-40.69-49.74-55.79-9.10-9.10
Short Term Coverage Ratio
0.00-1.10-4.87-1.60N/A-20.42-24.55-40.69-49.74-55.79-49.74-20.42
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A